The GLP is committed to full transparency. Download and review our 2019 Annual Report

Courts may suspend additional glyphosate trials as Bayer, plaintiffs negotiate possible settlement

| | January 9, 2020
roundup spray
Image: Grant Gerlock/Harvest Public Media
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Discussions are underway to postpone one or more highly anticipated Roundup cancer trials set to start in January, including trials scheduled for St. Louis, the former hometown of Roundup herbicide maker Monsanto Co., according to sources close to the litigation.

Court dockets still show trials scheduled for later this month in St. Louis and in California courts, and court officials say they are still planning for the trials to take place on the designated dates. But multiple legal sources said the opposing sides were nearing agreements that would put off the trials by several months, if not longer.

Bayer has been particularly uneasy about trials scheduled for St. Louis, where former Monsanto CEO Hugh Grant has been subpoenaed to testify and the trial of plaintiff Sharlean Gordon is to be broadcast to the public.

Related article:  Australia glyphosate-cancer class action lawsuit gets underway

Bayer and a team of plaintiffs’ attorneys have been pursuing a potential settlement of the litigation that could amount to well more than $8 billion, the legal sources said.

“Trial postponements make perfect sense right now,” said Susquehanna Financial Group analyst Tom Claps. “I believe that it is in everyone’s best interest to stay out of the courtroom at this time …. ”

Read full, original article: More Monsanto Roundup Cancer Trials Expected to be Postponed

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend